Treace Medical Concepts Securities Fraud Lawsuit
Analysis based on 12 articles · First reported Apr 17, 2025 · Last updated May 01, 2025
The market is impacted by the potential financial liabilities and reputational damage to Treace Medical Concepts due to the class action lawsuit. Investors who purchased shares during the class period may seek recovery for losses incurred from the alleged artificial inflation of the company's stock.
The Gross Law Firm has issued a notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) regarding a pending securities fraud class action lawsuit. The lawsuit alleges that Treace Medical Concepts made materially false and/or misleading statements and failed to disclose that competition negatively impacted the demand for its 'Lapiplasty' product, leading to a decline in revenue. Consequently, Treace Medical Concepts allegedly needed to accelerate plans for an alternative product to osteotomy. These alleged misrepresentations led to an artificial inflation of the company's stock price. Shareholders who purchased shares between May 8, 2023, and May 7, 2024, are encouraged to contact The Gross Law Firm to discuss lead plaintiff appointment, with a deadline of June 10, 2025.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard